FDA Unfairly ‘Maligning’ Responsible CBD Product Marketers – Council For Responsible Nutrition

Dietary supplement trade groups reacted on 26 November – in CRN’s case with umbrage – to the US Food and Drug Administration’s latest barrage of cannabidiol (CBD)-themed warning letters and accompanying update to consumers regarding CBD safety.

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration

Trade groups the Consumer Healthcare Products Association and Council for Responsible Nutrition took decidedly different tones in their reactions to the latest cannabidiol (CBD) developments at the US Food and Drug Administration.

CHPA applauded the agency 26 November for its warning letter blitz against companies illegally marketing CBD products.

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation